Nateglinide
CAS 105816-04-4
Overview
Nateglinide is a drug for the treatment of type 2 diabetes. Nateglinide was developed by Ajinomoto, a Japanese company and sold by the Swiss pharmaceutical company Novartis. Nateglinide belongs to the meglitinide class of blood glucose-lowering drugs
Anant Labs manufacture and furnish high quality Nateglinide impurities for global markets. Our Nateglinide EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Technical Data
Cat. No.ANT-NTG-00
CAS105816-04-4
Mol. FormulaC19H27NO3
Mol. Weight317.43 g/mol
IUPAC(2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid
SMILESCC(C)C1CCC(CC1)C(=O)N[C@H](CC2=CC=CC=C2)C(=O)O
InChIInChI=1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15?,16?,17-/m1/s1
InChI KeyOELFLUMRDSZNSF-OFLPRAFFSA-N
Note: We are upgrading our system, Cat No will change.
Synonyms
(2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acidnateglinide105816-04-4StarlixStarsissenaglinideFasticAY-4166SDZ-DJN-608Trazec
